Incyte and Genesis Therapeutics have agreed to discover and optimize at least two initial small molecule compounds through Genesis’s AI platform, Genesis Exploration of Molecular Space (GEMS).

Signals™ Notebook, the premier SaaS Electronic Laboratory Notebook used by 1 million scientists and powered by ChemDraw™ ...

The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

Nicholas Kristof is right to call for more treatment and prevention. However, by suggesting that drug decriminalization was ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

President Donald Trump’s 10% tariff rule on China could delay several pharmaceutical drugs imported to the US that many ...

From 2022 to 2023, there was a decrease in the age-adjusted rate of drug overdose death in the United States, according to a report published in the February Health E-Stats, a publication of the ...